Predictors of mortality in patients with chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 1, 2011, Pages 54-62

  Sarabanda, Alvaro Valentim Lima ^a,b   Marin Neto, José Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Clinical Arrhythmia and Pacemaker Unit   (Brazil)

Author keywords

Chagas' cardiomyopathy; mortality; risk stratification; ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SURVIVAL;

EID: 78651300264     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02896.x     Document Type: Article

References (22)

1. Organizacion Panamericana de la Salud. Estimacion cuantitativa de la enfermedad de Chagas en lãs Americas. Montevideo, Uruguay, Organizacion Panamericana de la Salud, 2006, p. 28.
2. Schmunis GA,. Epidemiology of Chagas disease in non-endemic countries: The role of international migration. Mem Inst Oswaldo Cruz 2007; 102 (Suppl. I): 75-85.
3. Rassi A Jr, Rassi A, Little WC,. Chagas' heart disease. Clin Cardiol 2000; 23: 883-889.
4. Marin Neto JA, SimAes MV, Sarabanda AV,. Chagas heart disease. Arq Bras Cardiol 1999; 72: 247-280.
5. Espinosa R, Carrasco HA, Belandria F, Fuenmayor AM, Molina C, Gonzalez R, Martinez O,. Life expectancy analysis in patients with Chagas' disease: Prognosis after one decade (1973-1983). Int J Cardiol 1985; 8: 45-56.
6. Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F,. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994; 90: 3098-3102.
7. Carrasco HA, Parada H, Guerrero L, Duque M, Duran D, Molina C,. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int J Cardiol 1994; 43: 27-38.
8. Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, et al,. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006; 355: 799-808.
9. Sarabanda AV, Sosa EA, SimAes MV, Figueiredo GL, Pintya AO, Marin-Neto JA,. Ventricular tachycardia in Chagas' heart disease: A comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or non-sustained forms. Int J Cardiol 2005; 102: 9-19.
10. Garzon SA, Lorga AM, Nicolau JC,. Electrocardiography in Chagas' heart disease. Sao Paulo Med J 1995; 113: 802-813.
11. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML,. Analysis of mortality events in the multicenter automatic defibrillator implantation trial. J Am Coll Cardiol 2004; 43: 1459-1465.
12. Hinkle LE, Thaler HT,. Clinical classification of cardiac deaths. Circulation 1982; 65: 457-464.
13. Marin-Neto JA, Marzullo P, Sousa AC, Marcassa C, Maciel BC, Iazigi N, L'Abbate A,. Radionuclide angiographic evidence for early predominant right ventricular involvement in patients with Chagas' disease. Can J Cardiol 1988; 4: 231-236.
14. Rassi A Jr, Rassi A, Rassi SG,. Predictors of mortality in chronic Chagas disease: A systematic review of observational studies. Circulation 2007; 115: 1101-1108.
15. Sternick EB, Martinelli-Filho M, Sampaio R, Gerken LM, Teixeira RA, Scarpelli R, Scanavacca M, et al,. Sudden cardiac death in patients with Chagas' heart disease and preserved left ventricular function. J Cardiovasc Electrophysiol 2006; 17: 113-116.
16. Rassi A Jr, Rassi SG, Rassi A,. Sudden death in Chagas' disease. Arq Bras Cardiol 2001; 76: 86-96.
17. Lorga AM, Lorga Filho A, D'Ãvila A, Rassi Jr A, Paola AAV, Pedrosa A, Costa AB, et al,. Sociedade Brasileira de Cardiologia. Guidelines for the evaluation and treatment of patients with cardiac arrhythmias. Arq Bras Cardiol 2002; 79 (Suppl 5): 1-50. (In Portuguese.)
18. Scanavacca MI, Sosa EA, Lee JH,. Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia. Arq Bras Cardiol 1990; 54: 367-371. (In Portuguese.)
19. Rassi A Jr, Dias JCP, Marin-Neto JA, Rassi A,. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart 2009; 95: 524-534.
20. Cardinalli-Neto A, Bestetti R, Cordeiro J, Rodrigues V,. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007; 18: 1236-1240.
21. Rassi A Jr,. Implantable cardioverter-defibrillators in patients with Chagas heart disease: Misperceptions, many questions and the urgent need for a randomized clinical trial. J Cardiovasc Electrophysiol 2007; 18: 1241-1243.
22. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, et al,; on behalf of the BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas'heart disease: The benznidazole evaluation for interrupting trypanosomiasis (BENEFIT). American Heart Journal 2008; 156: 37-43.